First Opinion S. Monica Soni People with terminal cancer need to know they are dying. Doctors shouldn’t withhold that information
First Opinion Holly Fernandez Lynch, Steven Joffe and Emily A. Largent ‘Is an abortion medically necessary?’ is not a question for ethicists to answer
First Opinion Klaudia Jaźwińska Implant recipients shouldn’t be left in the dark when a device maker cuts off support
Exclusive Megan Molteni Researchers revive abandoned technique in effort to make artificial human eggs in a test tube
First Opinion Barron H. Lerner Arthur Ashe and AIDS: Did the public have the right to know his diagnosis?
First Opinion Aaron Mitchell and Deborah Korenstein Drug companies’ payments and gifts affect physicians’ prescribing. It’s time to turn off the spigot
Health Megan Thielking ‘Traumatic as hell’: Patients describe what it’s like to be restrained in the ER
In the Lab Damian Garde Amid criticism, Stanford turns over review of its president to outside investigator
Health Tech Brittany Trang Twitter has spent years trying to combat health misinformation. Will Musk’s takeover make that harder?
Hospitals Tara Bannow and Kate Sheridan Harassment prompts children’s hospitals to strip websites, threatening access to gender-affirming care
Special Report Olivia Goldhill Tobacco giant Philip Morris is investing billions in health care. Critics say it’s peddling cures for its own poison
First Opinion Hans Gutbrod Addressing institutional trauma in health care: the case for a structured ethical framework
First Opinion Irene Shapiro The Morris ALS Principles: A model for empowering all disease communities
In the Lab Megan Molteni Buffalo shooting ignites a debate over the role of genetics researchers in white supremacist ideology
First Opinion Els Torreele Global health should not be determined by pharma investors and shareholders
The Pharmalot View Ed Silverman When should drugmakers go all in and cut off essential medicines to Russia?
Exclusive Megan Molteni New details emerge about a U.S. scientist’s obscured role in the ‘CRISPR babies’ scandal
Pharmalot Ed Silverman Few public biotech companies disclose environmental, social, and governance steps
First Opinion Lawrence O. Gostin and David Beier Race alone should not be used to allocate scarce Covid-19 treatments
First Opinion Hedy S. Wald, Herwig Czech and Shmuel P. Reis Doctors were complicit in Holocaust atrocities. Current and future health care workers need to know that
Health Andrew Joseph Hospitals are denying transplants for patients who aren’t vaccinated against Covid, with backing from ethicists
Health Megan Molteni First transplant of a genetically altered pig heart into a person sparks ethics questions
First Opinion Merith Basey It’s not the mission of universities to perpetuate inequity. Why do Emory and others do that?
First Opinion Fred D. Ledley Why the big questions about drug prices are rarely asked: It’s hard to do
In the Lab Megan Molteni Most advanced lab-grown human embryos prompt a pressing question: Are they getting too real?
Pharmalot Ed Silverman Obesity journal editor’s extensive company ties raise concerns about conflicts of interest in publishing
Health Megan Molteni Q&A: Bioethicist Leigh Turner on the worrisome boom in unregulated stem cell clinics
First Opinion Podcast Patrick Skerrett Listen: A physician and philosopher on the dangers of ‘curating’ natural deaths and executions